MEDLEY (FRA:3YV) NonCurrent Deferred Liabilities: €0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:3YV MEDLEY Inc FRA:3YV
76 GF Score
Price €11.30
GF Value €36.67
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is MEDLEY NonCurrent Deferred Liabilities?

MEDLEY FRA:3YV +0.89% 76 NonCurrent Deferred Liabilities is €0.0 Mil as of Dec. 2025. GuruFocus rates FRA:3YV with a GF Score™ of 76/100 and a GF Value™ of €36.67 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

MEDLEY's non-current deferred liabilities for the quarter that ended in Dec. 2025 was €0.0 Mil.

MEDLEY NonCurrent Deferred Liabilities Related Terms


MEDLEY NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for MEDLEY's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MEDLEY NonCurrent Deferred Liabilities Chart

MEDLEY Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

MEDLEY Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:3YV
76GF Score
MEDLEY Inc FRA:3YV
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of €0.0 Mil mean?
MEDLEY (FRA:3YV) has a NonCurrent Deferred Liabilities of €0.0 Mil as of Dec. 2025. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on MEDLEY and its competitors.
Is MEDLEY's NonCurrent Deferred Liabilities too high?
MEDLEY's current NonCurrent Deferred Liabilities is €0.0 Mil. Overall, MEDLEY has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MEDLEY's NonCurrent Deferred Liabilities compare to VEEV and BTSG?
MEDLEY's NonCurrent Deferred Liabilities of €0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Healthcare Providers & Services company?
A good NonCurrent Deferred Liabilities depends on the Healthcare Providers & Services industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on MEDLEY and its competitors. MEDLEY's current NonCurrent Deferred Liabilities is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDLEY stock overvalued right now?
Based on GuruFocus' analysis, MEDLEY (FRA:3YV) is currently considered Significantly Undervalued. The stock's GF Value™ is €36.67, compared to a current price of €11.30 — trading 69.2% below its estimated fair value. The current NonCurrent Deferred Liabilities is €0.0 Mil. MEDLEY's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For MEDLEY (FRA:3YV), the current NonCurrent Deferred Liabilities is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MEDLEY (FRA:3YV) Overvalued in 2026?

Based on GuruFocus' analysis, MEDLEY stock appears to be undervalued. The current stock price of €11.30 is trading 69.2% below its estimated GF Value™ of €36.67. GuruFocus considers MEDLEY to be Significantly Undervalued.

Key valuation signals for FRA:3YV:

  • NonCurrent Deferred Liabilities: €0.0 Mil
  • GF Value™: €36.67 vs. price of €11.30 (69.2% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the FRA:3YV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MEDLEY Business Description

Other Exchanges MDLYF:USA4480:Japan
Address 3-2-1 Roppongi, Minato-ku, 22nd Floor Sumitomo Fudosan Roppongi Grand Tower, Tokyo, JPN, 106-6222
MEDLEY Inc is engaged in providing medical information service for patients, and nursing care, a nursing care information service for citizens resolving issues in the field of medical healthcare. It provides its services through two platforms, Recruitment Platform Business which provides human resource recruitment systems in the medical and healthcare field and related businesses; and Medical Platform Business that is a telemedicine system for both patients and medical institutions.
76GF Score

Get the complete analysis for FRA:3YV

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.30
Price
€36.67
GF Value